Combination antiretroviral therapy with protease inhibitors in HIV-infected pregnancy.

Objective: To evaluate the possible association between protease inhibitor (PI) and premature birth and low birth-weight in HIV-infected pregnancies.

Materials And Methods: Data were collected retrospectively for maternal and pregnancy characteristics, antiretroviral medication, lowest CD4 count and highest viral load during pregnancy, and pregnancy outcomes. χ(2) Analysis, Student's t-test, and multiple logistic regression analysis were performed.

Placenta previa: does its type affect pregnancy outcome?

Our objective was to compare pregnancy outcomes associated with different types of placenta previa. This is a retrospective analysis of pregnancies complicated by placenta previa, from January 1990 to December 1997. Descriptive statistics and comparison analyses were performed.

Preeclampsia and eclampsia revisited.

Hypertensive disorders during pregnancy, which account for approximately 15% of pregnancy-related deaths, represent the second-leading cause of morbidity and mortality in the United States. New classifications recommended by the National Institutes of Health's Working Group on High Blood Pressure in Pregnancy have decreased the confusion often associated with these disorders. The cause of preeclampsia-eclampsia still remains elusive, but continued research has provided hope with regard to screening, improved diagnosis, and management.